Novel role of triazenes in haematological malignancies: Pilot study of Temozolomide, Lomeguatrib and IL-2 in the chemo-immunotherapy of acute leukaemia

This publication has 47 references indexed in Scilit:

• Current therapeutic strategies for acute myeloid leukaemia
  British Journal of Haematology, 2006
• The multifaceted mismatch-repair system
  Nature Reviews Molecular Cell Biology, 2006
• O6-(4-Bromothenyl)guanine (PaTrin-2), a novel inhibitor of O6-alkylguanine DNA alkyl-transferase, increases the inhibitory activity of temozolomide against human acute leukaemia cells in vitro
  Pharmacological Research, 2006
• Systemic therapy for advanced uterine sarcoma: A systematic review of the literature
  Gynecologic Oncology, 2005
• Temozolomide in the treatment of recurrent malignant glioma
  Cancer, 2004
• The Effect of O6-Alkylguanine-DNA Alkyltransferase and Mismatch Repair Activities on the Sensitivity of Human Melanoma Cells to Temozolomide, 1,3-bis(2-Chloroethyl)1-nitrosourea, and Cisplatin
  The Journal of Pharmacology and Experimental Therapeutics, 2003
• A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815
  International Journal of Immunopharmacology, 1996
• Untreated or drug-treated tumor cells are differentially recognized by allogeneic lymphocytes
  International Journal of Immunopharmacology, 1994
• IL-2 reverses the inhibition of cytotoxic T-cell responses induced by 5-(3,3′ dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in vitro
  International Journal of Immunopharmacology, 1990
• Combined effects of antineoplastic agents and anti-lymphoma allograft reactions
  Published by Elsevier ,1980